Cardinal Health, Inc. $CAH Shares Sold by Sector Gamma AS

Sector Gamma AS decreased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 9.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 59,536 shares of the company’s stock after selling 6,464 shares during the quarter. Cardinal Health comprises about 2.3% of Sector Gamma AS’s portfolio, making the stock its 14th biggest holding. Sector Gamma AS’s holdings in Cardinal Health were worth $9,345,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of CAH. Baird Financial Group Inc. increased its position in Cardinal Health by 107.2% during the second quarter. Baird Financial Group Inc. now owns 99,393 shares of the company’s stock worth $16,698,000 after purchasing an additional 51,416 shares during the last quarter. Voya Investment Management LLC grew its stake in shares of Cardinal Health by 298.3% in the 3rd quarter. Voya Investment Management LLC now owns 821,723 shares of the company’s stock valued at $128,978,000 after buying an additional 615,398 shares during the period. Nomura Holdings Inc. increased its holdings in shares of Cardinal Health by 568.0% during the 2nd quarter. Nomura Holdings Inc. now owns 85,293 shares of the company’s stock worth $14,329,000 after buying an additional 72,525 shares during the last quarter. Marshall Wace LLP raised its position in shares of Cardinal Health by 19.1% during the 2nd quarter. Marshall Wace LLP now owns 1,930,967 shares of the company’s stock valued at $324,402,000 after buying an additional 309,335 shares during the period. Finally, Columbus Macro LLC raised its position in shares of Cardinal Health by 102.8% during the 3rd quarter. Columbus Macro LLC now owns 36,529 shares of the company’s stock valued at $5,734,000 after buying an additional 18,516 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on CAH. Deutsche Bank Aktiengesellschaft increased their price objective on Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a research report on Tuesday, November 18th. Citigroup upgraded Cardinal Health from a “neutral” rating to a “buy” rating and increased their price target for the stock from $190.00 to $244.00 in a report on Friday, January 9th. Argus boosted their price objective on shares of Cardinal Health from $211.00 to $232.00 and gave the company a “buy” rating in a report on Friday. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. Finally, Robert W. Baird set a $250.00 price target on shares of Cardinal Health in a research note on Wednesday, January 14th. Fourteen equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus target price of $221.07.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $208.29 on Friday. The stock has a market capitalization of $49.49 billion, a price-to-earnings ratio of 31.42, a price-to-earnings-growth ratio of 1.41 and a beta of 0.65. The business has a 50-day moving average of $205.78 and a 200 day moving average of $176.26. Cardinal Health, Inc. has a 12 month low of $120.72 and a 12 month high of $215.48.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.22 by $0.33. The business had revenue of $64.01 billion for the quarter, compared to analysts’ expectations of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The business’s quarterly revenue was up 22.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd were given a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend was Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.